CN Stock MarketDetailed Quotes
600538 Beihai Gofar Chuanshan Biological
- 5.44
- 0.000.00%
Market Closed Dec 13 15:00 CST
2.85BMarket Cap-32.57P/E (TTM)
5.60High5.35Low180.48KlotVolume5.48Open5.44Pre Close98.65MTurnover3.44%Turnover RatioLossP/E (Static)524.20MShares5.8052wk High3.36P/B2.85BFloat Cap2.9052wk Low5.98Limit Up524.20MShs Float19.58Historical High4.90Limit Down4.60%Amplitude1.85Historical Low--Dividend TTM5.47Avg Price83.37KlotAsk--Div YieldTTM100Lot Size94.72KlotBid
About Beihai Gofar Chuanshan Biological Company
The company was founded in 1993 and is an enterprise mainly engaged in the wholesale business. The main industries the company operates include pharmaceutical manufacturing and pharmaceutical distribution industries, judicial IVD (in vitro diagnosis) technical services, molecular medical imaging centers, tumor radiotherapy centers, and oncology telemedicine technical services. The company's main products include “Haibao” brand pearl eye drops, pearl powder, pearl layer powder, gastrointestinal relief granules, ethanol disinfectant, etc. Corporate honors: “Best Practice for Listed Companies 2022 Report Performance Briefing”, National Key New Products, National Key New Products, Beihai Guofa Biopesticides Award Certificate, etc.
Company Profile
Short Name-A国发股份
Symbol-A600538
Company NameBeihai Gofar Chuanshan Biological Co., Ltd.
Listing DateJan 14, 2003
Issue Price6.69
Shares Offered45.00M share(s)
FoundedJan 22, 1993
Listed ExchangeSH Stock Exchange
Legal Representativeyedai jiang
Secretaryyong li
Accounting FirmTianjian Certified Public Accountants (Special General Partnership)
Securities Representativeliping li
Legal CounselBeijing Times Jiuhe Law Firm
Employees157
Phone0779-3200619
Office AddressNo. 3 Beibuwan Middle Road, Beihai City, Guangxi Zhuang Autonomous Region
Zip Code536000
Registered AddressNo. 3 Beibuwan Middle Road, Beihai City, Guangxi Zhuang Autonomous Region
Fax0779-3200618
Emailsecurities@gofar.com.cn
Websitehttp://www.gofar.com.cn
Business License450500000008877
BusinessLicense projects: pharmaceutical wholesale; pharmaceutical retail; pharmaceutical production; production of second-class medical devices; production of disinfectants (excluding hazardous chemicals); medical services; real estate development and operation. (Projects requiring approval according to law can only carry out business activities after approval by relevant departments. Specific business projects are subject to the relevant department's approval documents or licenses). General projects: medical research and experimental development; research and development of marine bioactive substance extraction, purification, synthesis technology; investment activities with own funds; technical services, technology development, technical consultation, technical exchange, technology transfer, technology promotion; non-residential real estate leasing; advertising; sales of arts and crafts and ceremonial goods (other than ivory and its products); sales of class II medical devices; sales of disinfectants (excluding hazardous chemicals). (With the exception of projects subject to approval according to law, business activities are carried out independently in accordance with the law on the basis of a business license).
Company Executives
- Name
- Position
- Salary
- ye jiang
- Acting Chairman, Directors
- --
- peicheng wu
- Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee
- 80.00K
- zhibo yin
- Directors, VP, Chief Financial Officer, Strategy Committee Member
- 1.00M
- tao peng
- Directors, Strategy Committee Member
- 80.00K
- yong li
- Directors, Board Secretary, VP
- 941.60K
- xiaofang song
- Independent Directors, Member of the Remuneration and Assessment Committee, Chairman of the Audit Committee
- 100.00K
- yanlin ceng
- Independent Directors, Chairman of the Nomination Committee, Strategy Committee Member
- 41.70K
- zeyang xu
- Independent Directors, Audit Committee Member, Nomination Committee Members, Chairman of the Remuneration and Assessment Committee
- 100.00K
- liping li
- Securities Affairs Representative
- --
- qiujun lv
- Chairman of the Supervisory Board, Auditors
- 80.00K
- zhenhua huang
- Auditors
- 50.00K
- libin pan
- Senior Advisors
- 1.85M
- yan chen
- Employee Supervisors
- 212.90K
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
